: What Merck’s antiviral pill could mean for vaccine hesitancy — ‘It’s not a magic pill’

Merck and Ridgeback Therapeutics say molnupiravir cuts the risk of death or hospitalization in half

Merck and Ridgeback Therapeutics say molnupiravir cuts the risk of death or hospitalization in half